US Stock MarketDetailed Quotes

SUPN Supernus Pharmaceuticals

Watchlist
  • 30.190
  • -0.410-1.34%
Trading Apr 30 13:07 ET
1.66BMarket Cap1509.50P/E (TTM)

Supernus Pharmaceuticals Key Stats

Supernus Pharmaceuticals Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings Estimates

May 8, 2024

Revenue(YoY)

145.83M

-5.16%
EPS(YoY)

-0.08

-127.55%

Buy

Apr 8, 2024

Supernus Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 148.793M--
May 8, 20242024/Q1-- / 145.832M--
Feb 27, 20242023/Q4164.314M / 155.031M--
Nov 8, 20232023/Q3153.880M / 143.387M--
Aug 8, 20232023/Q2135.563M / 143.658M--
May 9, 20232023/Q1153.764M / 139.023M--
--2022/Q4167.328M / 180.375M--
Nov 8, 20222022/Q3177.353M / 172.476M--
Aug 4, 20222022/Q2170.051M / 164.229M--
May 9, 20222022/Q1152.506M / 150.471M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 148.793M--
May 8, 20242024/Q1-- / 145.832M--
Feb 27, 20242023/Q4164.314M / 155.031M--
Nov 8, 20232023/Q3153.880M / 143.387M--
Aug 8, 20232023/Q2135.563M / 143.658M--
May 9, 20232023/Q1153.764M / 139.023M--
--2022/Q4167.328M / 180.375M--
Nov 8, 20222022/Q3177.353M / 172.476M--
Aug 4, 20222022/Q2170.051M / 164.229M--
May 9, 20222022/Q1152.506M / 150.471M--

Unlock Free Earnings Estimates

Supernus Pharmaceuticals Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 8, 2024

Buy

  • Buy

    66.67%
  • Hold

    33.33%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg